HTGM logo

HTGM EBIT

Annual EBIT

-$20.73 M
-$4.67 M-29.07%

December 31, 2022

Summary

Performance

1-Year Change

-29.07%

3-Year Change

-13.04%

5-Year Change

-17.44%

15-Year Change

-17.44%

HTGM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$11.56 M

3-Year Low

-$20.73 M
HTGM annual earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
HTGM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
HTGM next annual earnings announcement has not yet been scheduled

OtherHTGMprofitabilitymetrics:

Annual Revenue

$6.37 M
HTGM annual revenue is $6.37 million

Annual Net Income

-$21.59 M
HTGM annual net profit is -$21.59 million

Annual EBITDA

-$20.14 M
HTGM annual EBITDA is -$20.14 million

Annual EPS

-$24.28
HTGM annual earnings per share is -$24.28

Quarterly EBIT

-$4.91 M
-$394.00 K-8.72%

March 31, 2023

Summary

Performance

3-Month Change

-8.72%

1-Year Change

+21.35%

3-Year Change

+5.99%

5-Year Change

+5.45%

HTGM Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.66 M

3-Year Low

-$6.25 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HTGM previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HTGM next earnings announcement has not yet been scheduled

OtherHTGMprofitabilitymetrics:

Quarterly Revenue

$1.03 M
HTGM quarterly revenue is $1.03 million

Quarterly Net Income

-$5.05 M
HTGM quarterly net profit is -$5.05 million

Quarterly EBITDA

-$4.83 M
HTGM quarterly EBITDA is -$4.83 million

Quarterly EPS

-$2.28
HTGM quarterly earnings per share is -$2.28

TTM EBIT

-$19.39 M
+$1.33 M+6.43%

March 31, 2023

Summary

Performance

3-Month Change

+6.43%

1-Year Change

-9.38%

3-Year Change

-5.24%

5-Year Change

-5.76%

HTGM TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$2.58 M

3-Year Low

-$21.13 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HTGM previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HTGM next earnings announcement has not yet been scheduled

OtherHTGMprofitabilitymetrics:

TTM Revenue

$6.21 M
HTGM TTM revenue is $6.21 million

TTM Net Income

-$20.15 M
HTGM TTM net profit is -$20.15 million

TTM EBITDA

-$18.91 M
HTGM TTM EBITDA is -$18.91 million

TTM EPS

-$17.80
HTGM TTM earnings per share is -$17.80

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$20.73 M
HTGM annual earnings before interest & taxes is -$20.73 million

Annual Revenue

$6.37 M
HTGM annual revenue is $6.37 million

Annual Cost Of Goods Sold

$4.57 M
HTGM annual cost of goods sold is $4.57 million

Annual Operating Expenses

$22.62 M
HTGM annual total operating expenses is $22.62 million

HTGM EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-29.1%+21.4%-9.4%
3 y3 years-13.0%+6.0%-5.2%
5 y5 years-17.4%+5.5%-5.8%

HTGM EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+29.1%at low+13.9%+27.1%+20.8%+8.9%
5 y5-year+29.1%at low+110.2%+27.1%+28.0%+8.9%
alltimeall time+79.3%+16.6%+195.8%+34.9%+650.5%+25.0%

HTG Molecular Diagnostics EBIT History

DateAnnualQuarterlyTTM
Mar 2023
-
-$4.91 M(+8.7%)
-$19.39 M(-6.4%)
Dec 2022
-$20.73 M(+29.1%)
-$4.52 M(+4.8%)
-$20.73 M(-1.9%)
Sep 2022
-
-$4.31 M(-23.6%)
-$21.13 M(+0.4%)
Jun 2022
-
-$5.64 M(-9.7%)
-$21.04 M(+18.6%)
Mar 2022
-
-$6.25 M(+26.9%)
-$17.73 M(+10.4%)
Dec 2021
-$16.06 M(-19.0%)
-$4.92 M(+16.6%)
-$16.06 M(+6.0%)
Sep 2021
-
-$4.22 M(+80.6%)
-$15.15 M(-5.7%)
Jun 2021
-
-$2.34 M(-48.9%)
-$16.06 M(-16.2%)
Mar 2021
-
-$4.58 M(+14.0%)
-$19.18 M(-3.3%)
Dec 2020
-$19.83 M(+8.1%)
-$4.01 M(-21.9%)
-$19.83 M(-0.7%)
Sep 2020
-
-$5.14 M(-5.8%)
-$19.96 M(+3.3%)
Jun 2020
-
-$5.45 M(+4.3%)
-$19.33 M(+4.9%)
Mar 2020
-
-$5.23 M(+26.1%)
-$18.43 M(+0.5%)
Dec 2019
-$18.34 M(+17.9%)
-$4.15 M(-7.9%)
-$18.34 M(+14.1%)
Sep 2019
-
-$4.50 M(-1.1%)
-$16.07 M(-0.7%)
Jun 2019
-
-$4.55 M(-11.4%)
-$16.17 M(+4.4%)
Mar 2019
-
-$5.14 M(+173.8%)
-$15.49 M(-0.4%)
Dec 2018
-$15.55 M
-$1.88 M(-59.3%)
-$15.55 M(+1.4%)
Sep 2018
-
-$4.61 M(+19.2%)
-$15.33 M(-3.0%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$3.87 M(-25.6%)
-$15.80 M(-9.3%)
Mar 2018
-
-$5.20 M(+212.9%)
-$17.43 M(-1.2%)
Dec 2017
-$17.65 M(-27.0%)
-$1.66 M(-67.3%)
-$17.65 M(-16.8%)
Sep 2017
-
-$5.08 M(-7.5%)
-$21.21 M(-4.1%)
Jun 2017
-
-$5.49 M(+1.4%)
-$22.13 M(-3.6%)
Mar 2017
-
-$5.42 M(+3.7%)
-$22.95 M(-5.0%)
Dec 2016
-$24.16 M(+22.8%)
-$5.22 M(-12.9%)
-$24.16 M(-0.3%)
Sep 2016
-
-$6.00 M(-5.0%)
-$24.24 M(+5.3%)
Jun 2016
-
-$6.31 M(-4.8%)
-$23.03 M(+1.5%)
Mar 2016
-
-$6.63 M(+25.0%)
-$22.69 M(+15.4%)
Dec 2015
-$19.67 M(+48.4%)
-$5.30 M(+11.0%)
-$19.67 M(+8.7%)
Sep 2015
-
-$4.78 M(-20.0%)
-$18.09 M(+9.9%)
Jun 2015
-
-$5.98 M(+65.6%)
-$16.46 M(+16.6%)
Mar 2015
-
-$3.61 M(-3.1%)
-$14.11 M(+6.5%)
Dec 2014
-$13.25 M(+14.7%)
-$3.72 M(+18.4%)
-$13.25 M(+9.4%)
Sep 2014
-
-$3.15 M(-13.3%)
-$12.11 M(+35.1%)
Jun 2014
-
-$3.63 M(+31.8%)
-$8.97 M(+68.0%)
Mar 2014
-
-$2.75 M(+6.5%)
-$5.34 M(+106.5%)
Dec 2013
-$11.56 M(-7.7%)
-$2.58 M
-$2.58 M
Dec 2012
-$12.52 M
-
-

FAQ

  • What is HTG Molecular Diagnostics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics annual EBIT year-on-year change?
  • What is HTG Molecular Diagnostics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics quarterly EBIT year-on-year change?
  • What is HTG Molecular Diagnostics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics TTM EBIT year-on-year change?

What is HTG Molecular Diagnostics annual earnings before interest & taxes?

The current annual EBIT of HTGM is -$20.73 M

What is the all time high annual EBIT for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high annual earnings before interest & taxes is -$11.56 M

What is HTG Molecular Diagnostics annual EBIT year-on-year change?

Over the past year, HTGM annual earnings before interest & taxes has changed by -$4.67 M (-29.07%)

What is HTG Molecular Diagnostics quarterly earnings before interest & taxes?

The current quarterly EBIT of HTGM is -$4.91 M

What is the all time high quarterly EBIT for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high quarterly earnings before interest & taxes is -$1.66 M

What is HTG Molecular Diagnostics quarterly EBIT year-on-year change?

Over the past year, HTGM quarterly earnings before interest & taxes has changed by +$1.33 M (+21.35%)

What is HTG Molecular Diagnostics TTM earnings before interest & taxes?

The current TTM EBIT of HTGM is -$19.39 M

What is the all time high TTM EBIT for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high TTM earnings before interest & taxes is -$2.58 M

What is HTG Molecular Diagnostics TTM EBIT year-on-year change?

Over the past year, HTGM TTM earnings before interest & taxes has changed by -$1.66 M (-9.38%)